Madrigal Pharmaceuticals
The Vice President, Clinical Development Program Leader is a senior clinical leadership role responsible for shaping and executing clinical strategy across therapeutic programs from early development through registration. This position involves leading cross-functional teams, overseeing clinical trial design and regulatory interactions, and ensuring scientific rigor and patient safety. The role requires extensive experience in clinical development, translational medicine, and global regulatory affairs to drive assets from preclinical stages through commercialization.
Headquarters
Conshohocken, Pennsylvania, United States
Company Size
201-500 employees
Founded
2016
Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to halt or reverse […]
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2 weeks ago
Director of Preclinical & Clinical Science
Wellfound
Medical Director, Clinical Development
Regeneron Pharmaceuticals
Medical Director - Clinical Development - Endocrinology and Autoimmune Diseases
AbCellera
Vice President of Translational Medicine
Flagship Pioneering, Inc.
Senior Scientist II/Principal Research Scientist I - Translational Program Science
AbbVie
Medical Director, Clinical Sciences, MASH/Metabolism (Regeneron Genetics Medicine)
Regeneron Pharmaceuticals